Patients &
Families

Our Purpose

Cogent has a deep commitment to the research and development of precision therapies, but more than that, we are dedicated to listening and learning from people who are living with or caring for loved ones with the diseases we serve. We strive to go beyond our research and clinical trials by providing patients and their families educational resources and information through advocacy partnerships and educational programs.

Systemic mastocytosis is a rare disorder that causes your body to make too many mast cells. There are two types of systemic mastocytosis: Advanced and Nonadvanced.

GIST is a rare cancer affecting the gastrointestinal (GI) tract. In most cases, GISTs arise in the stomach or small intestine, but can form anywhere along the digestive tract.

Patient advocacy & engagement
Cogent’s Patient Advocacy & Engagement team works to amplify the patient voice and serves as a liaison between our company and members of the patient, caregiver and advocacy communities. We strive to help educate and empower people affected by the diseases we serve through partnerships with patient advocates and advocacy groups. We view the patient community as experts in their disease. Our goal is to listen to and learn from the patient and caregiver community to help us make informed decisions about our programs. Our employees regularly participate in community and advocacy events to help increase awareness and support people affected by serious diseases and cancers.

A Message from Cogent’s
Chief Patient Officer

“It’s an honor and privilege to serve as Cogent’s Chief Patient Officer. Our partnership with the patient community is one that we truly value. My goal is to ensure that the patient’s voice is heard and incorporated into our development programs as early and often as possible. When we engage directly with patient advocates, patients and caregivers and the broader healthcare community, we can constantly learn and innovate as we work toward our mission of bringing precision therapies to patients with clear unmet need.”

Dana Martin, PharmD

Senior Vice President, Medical Affairs
& Chief Patient Officer

Meet Cogent’s Patient Advocacy &
Engagement Team
patients-families-team-lora-m.png
LORA MARDEN

Vice President, Patient Advocacy, Engagement & Innovation

patients-families-team-dana-m.png
DANA MARTIN, PharmD

Senior Vice President, Medical Affairs & Chief Patient Officer

patients-families-team-hilary-d.png
HILARY D’ANNA

Associate Director, Patient Advocacy & Engagement

patients-families-team-susan-f.png
SUSAN FOLEY

Senior Director, Patient Advocacy & Engagement

Our guiding principles

Respect the independence of patient advocacy groups regarding their mission, decisions, and activities

Seek to understand unmet needs by listening and learning from patient advocacy groups, patient advocates, and the patient communities
we serve

Ensure the patient voice is included in all aspects of our business: from drug development through commercialization

Be transparent in our communications and help educate the community using medically accurate communications and resources that are backed by sound data

Hold ourselves to the highest levels of ethics and integrity and comply with rules and regulations for interactions with patient advocacy groups

Are you a Patient Advocacy Group or Advocate who is interested in helping Cogent raise awareness or to share your experience? Please reach out to us at:
Patientadvocacy@cogentbio.com

Scroll to Top
All Categories
lead-Cole-P
Cole Pinnow

Chief Commercial Officer

Cole is an accomplished executive with extensive commercial development, new product launch, P&L, and strategic leadership experience over a 20 plus year career in the pharmaceutical industry, with a specific focus on oncology. Before joining Cogent as Chief Commercial Officer, he served at Pfizer as the Global Franchise Lead for its Genitourinary, Lung and Breast Oncology Businesses. In this role, he oversaw the global launch and lifecycle strategy for Xtandi® + Talzenna® in mCRPC. Before that, he was President of Pfizer Canada where he was accountable for the company’s operations within the country, including sales, marketing, access and government relations. He was also VP of a US commercial business unit which had tremendous growth under his leadership. Prior to working at Pfizer, Cole held management positions at both Hospira, Inc., a global pharmaceutical and medical device company, in global pharmaceuticals, global marketing and commercial development. He holds an MBA from the University of Chicago Booth School of Business, a Master of Science degree in Microbiology from Iowa State University, and a Bachelor’s Degree in Biology from St. Olaf College. In his spare time, Cole enjoys swimming, hiking and skiing.